Simvastatin improves final visual outcome in acute optic neuritis: a randomized study

Anna Tsakiri; Klaus Kallenbach; Dan Fuglø; Benedikte Wanscher; Henrik Larsson; Jette Frederiksen

doi:10.1177/1352458511415452

Simvastatin improves final visual outcome in acute optic neuritis: a randomized study

Anna Tsakiri, Klaus Kallenbach, Dan Fuglø, Benedikte Wanscher, Henrik Larsson, Jette Frederiksen

52 Citationer (Scopus)

Abstract

In recent years, small-scale clinical trials have indicated that statins or 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitors exert pleiotropic immunomodulatory effects, with potential therapeutic implications in multiple sclerosis (MS).

Originalsprog	Engelsk
Tidsskrift	Multiple Sclerosis
Vol/bind	18
Udgave nummer	1
Sider (fra-til)	72-81
Antal sider	10
ISSN	1352-4585
DOI	https://doi.org/10.1177/1352458511415452
Status	Udgivet - 2012

Adgang til dokumentet

10.1177/1352458511415452

Citationsformater

@article{9df99f3118244fcd9473680f745e719c,

title = "Simvastatin improves final visual outcome in acute optic neuritis: a randomized study",

abstract = "In recent years, small-scale clinical trials have indicated that statins or 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitors exert pleiotropic immunomodulatory effects, with potential therapeutic implications in multiple sclerosis (MS).",

author = "Anna Tsakiri and Klaus Kallenbach and Dan Fugl{\o} and Benedikte Wanscher and Henrik Larsson and Jette Frederiksen",

year = "2012",

doi = "10.1177/1352458511415452",

language = "English",

volume = "18",

pages = "72--81",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Simvastatin improves final visual outcome in acute optic neuritis

T2 - a randomized study

AU - Tsakiri, Anna

AU - Kallenbach, Klaus

AU - Fuglø, Dan

AU - Wanscher, Benedikte

AU - Larsson, Henrik

AU - Frederiksen, Jette

PY - 2012

Y1 - 2012

N2 - In recent years, small-scale clinical trials have indicated that statins or 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitors exert pleiotropic immunomodulatory effects, with potential therapeutic implications in multiple sclerosis (MS).

AB - In recent years, small-scale clinical trials have indicated that statins or 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitors exert pleiotropic immunomodulatory effects, with potential therapeutic implications in multiple sclerosis (MS).

U2 - 10.1177/1352458511415452

DO - 10.1177/1352458511415452

M3 - Journal article

C2 - 21921071

SN - 1352-4585

VL - 18

SP - 72

EP - 81

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 1

ER -

Simvastatin improves final visual outcome in acute optic neuritis: a randomized study

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater